To date, there are few studies evaluating the level of CD39 in CSCs; however, one study indicates that CD39 is expressed at high levels in glioma cancer stem cells compared to non-stem glioma cells [29]. This evidence concerns the gene ENTPD1 and central nervous system cancer.